GC Corp. (KRX:005250)
South Korea · Delayed Price · Currency is KRW 9,230.00
+90.00 (0.98%)
Nov 2, 2026, 3:30 PM KST
GC Corp. Market Cap
GC Corp. has a market cap or net worth of 419.42 billion as of October 30, 2026. It is the 17,670th most valuable company in the world and the 500th biggest in South Korea. Its market cap has decreased by 41.38% in one year.
Market Cap
419.42B
Enterprise Value
2.88T
Revenue
2.49T
Global Rank
Country Rank
#500 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since January 4, 1993, GC Corp.'s market cap has increased from 52.72B to 419.42B, an increase of 695.53%. That is a compound annual growth rate of 6.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 419.42B | -41.97% |
| Dec 30, 2025 | 722.80B | -8.08% |
| Dec 30, 2024 | 786.36B | 5.93% |
| Dec 28, 2023 | 742.32B | -3.82% |
| Dec 29, 2022 | 771.83B | -37.38% |
| Dec 30, 2021 | 1.23T | -34.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 624.39B |
| Proteina | 599.21B |
| Pharmicell | 564.04B |
| Onconic Therapeutics | 549.89B |
| Hyundai Bioscience | 518.22B |
| GI Innovation | 434.19B |
| Medy-Tox | 412.68B |
| AbClon | 368.52B |